G Protein Coupled Receptors Molecular Pharmacology Offers a Unique View of Academic and Applied Approaches to Pharmaceutical Research
Posted on: Thursday, 22 November 2007, 09:00 CST
Research and Markets (http://www.researchandmarkets.com/reports/c75212) has announced the addition of "G Protein-coupled Receptors: Molecular Pharmacology" to their offering.
G protein-coupled receptors (GPCRs) are membrane proteins that transduce a vast array of extracellular signals into intracellular reactions ranging from cell-cell communication processes to physiological responses. They play an important role in a variety of diseases from cancer and diabetes, to neurodegenerative, inflammatory and respiratory disorders. GPCRs are therefore of utmost interest in drug development: over half of all prescription drugs currently on the market act by targeting these receptors directly or indirectly.
G Protein-coupled Receptors: Molecular Pharmacology provides a clear summary of the current knowledge in this fast-evolving field. The book sets out with an introduction to signalling molecules and their receptors, and an overview of the technical approaches used to investigate these interactions. Structural, functional and especially pharmacological aspects of GPCRs are then discussed in more detail and much attention is devoted to the analysis and interpretation of experimental data. The now widespread use of recombinant cell lies, receptor mutants and related artifices in drug research is critically evaluated. Special attention is also devoted to topical but often poorly understood concepts, such as insurmountable antagonism, inverse agonism and allosteric interactions.
By combining general information with the major state-of-the-art concepts in GPCR-research, this outstanding book equips the reader with the necessary background for understanding and critically evaluating the current literature.
Written by two experts from academia and industry, G Protein-coupled Receptors: Molecular Pharmacology offers a unique view of academic and applied approaches aiming to reveal new ideas in pharmaceutical research.
The book is of interest to anyone involved in drug development and preclinical research and those who need to function within multi-disciplinary teams in the pharmaceutical industry: from investigators to product managers or clinicians who seek to have a broad mechanistic understanding of drug-receptor interactions. It is also an invaluable resource for final year undergraduate and postgraduate students in pharmacology and cell and molecular biology
Contents:
FOREWORD
A) CHEMICAL MESSENGERS AND THE CELL MEMBRANE
B) RADIOLIGAND BINDING STUDIES
C) FUNCTIONAL STUDIES
D) G PROTEIN-COUPLED RECEPTORS
E) CONCLUDING REMARKS
For more information visit http://www.researchandmarkets.com/reports/c75212
Source: Business Wire
Related Articles
- India's Non-Small-Cell Lung Cancer Drug Market Will Almost Double by 2013
- Chinese Non-Small-Cell Lung Cancer Drug Market Will More Than Double by 2013
- Small-Cell Lung Cancer Drug Market Will More Than Double to Over $684 Million in 2017
- The Book 'Proteins: From Analytics to Structural Genomics' Clusters Well With the Program on Protein Science and Molecular Biology
- Cytori Therapeutics Names John Ransom, Ph.D., Vice President of Research, Regenerative Cell Technology
- Astex Announces New Licensing and Drug Discovery Alliance to Develop Novel Cell Cycle Cancer Drugs
- Anomalous Diffusion of Proteins Due to Molecular Crowding
- Research and Markets: Pharmaceutical Research Profiting From Cell-Based Molecular Imaging
- Dysregulation of Insulin Receptor Substrate 2 in Cells and Brain Causes Obesity and Diabetes
- Pro: Greater Funding of Cell and Molecular Biology Has Delivered What Was Promised to Respiratory Medicine
 |
 |
User Comments (0)
RSS Feeds